Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.08.03
华融证券股份有限公司关于公司公开发行2016年公司债券重大事项受托管理事务临时报告
2017.08.02
关于筹划发行股份购买资产的停牌进展公告
2017.07.29
2017年半年度业绩快报
2017.07.26
关于筹划发行股份购买资产的停牌进展公告
2017.07.25
独立董事发生变动的公告
2017.07.22
2017年第二次临时股东大会的法律意见书
2017.07.22
2017年第二次临时股东大会决议公告
2017.07.22
关于筹划发行股份购买资产继续停牌公告
2017.07.19
关于筹划发行股份购买资产的停牌进展公告
2017.07.18
关于召开2017年第二次临时股东大会的提示性公告
第一页
上一页
75
76
77
78
79
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
